Chemotherapy is the main method of treating malignant tumors in clinical treatment.
However, the commonly used chemotherapeutic drugs have the disadvantages of high …

The success of several FDA-approved platinum anticancer drugs has stimulated increasing
interest in the development of new metallodrugs.[1] Ruthenium (Ru) complexes are potential …

Theranostic systems by integrating the tumor imaging and tumor therapeutic capabilities into
one platform have attracted numerous attentions from worldwide researchers. Despite the …

Small interfering RNA (siRNA) is emerging as a novel therapeutic for treating various
diseases, provided a safe and efficient delivery is available. In particular, specific delivery to …

Proteins, a type of natural biopolymer that possess many prominent merits, have been
widely utilized to engineer nanomedicine for fighting against cancer. Motivated by their ever …

Multidrug resistance (MDR), defined as the ability of cancer cells to gain resistance to both
conventional and novel chemotherapy agents, is an important barrier in treating …

Immunological adjuvants are essential for successful cancer vaccination. However,
traditional adjuvants have some limitations, such as lack of controllability and induction of …

Dendrimers, a class of synthetic macromolecules which are notable for their well-defined
ramified structures and unique multivalent cooperativity, hold great promise for developing …

Gastric cancer (GC) results from deregulated cell growth in the stomach. Despite significant
efforts and recent advancements in the treatment of gastric cancer, it remains a life …

Despite that great progression has been made in nanoparticulate drug delivery systems
(nano-DDS), multiple drug delivery dilemmas still impair the delivery efficiency of …